Total Payments
$6,486
2024 Payments
$348.61
Companies
33
Transactions
326
Medicare Patients
3,667
Medicare Billing
$1.4M
Payment Breakdown by Category
Food & Beverage$6,119 (94.3%)
Consulting$350.00 (5.4%)
Education$14.94 (0.2%)
Research$2.02 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,119 | 323 | 94.3% |
| Consulting Fee | $350.00 | 1 | 5.4% |
| Education | $14.94 | 1 | 0.2% |
| Unspecified | $2.02 | 1 | 0.0% |
Payments by Type
General
$6,484
325 transactions
Research
$2.02
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,250 | 79 | $0 (2024) |
| UCB, Inc. | $959.55 | 64 | $0 (2023) |
| Promius Pharma LLC | $565.25 | 7 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $483.77 | 25 | $0 (2022) |
| Janssen Biotech, Inc. | $473.71 | 44 | $0 (2024) |
| PFIZER INC. | $442.02 | 13 | $0 (2023) |
| Celgene Corporation | $344.76 | 35 | $0 (2019) |
| Sun Pharmaceutical Industries Inc. | $325.74 | 14 | $0 (2022) |
| GENZYME CORPORATION | $147.62 | 5 | $0 (2023) |
| GlaxoSmithKline, LLC. | $125.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $348.61 | 27 | Janssen Biotech, Inc. ($170.83) |
| 2023 | $634.97 | 35 | Amgen Inc. ($198.55) |
| 2022 | $984.13 | 59 | Amgen Inc. ($256.76) |
| 2021 | $736.77 | 49 | Amgen Inc. ($206.21) |
| 2020 | $671.06 | 39 | UCB, Inc. ($234.11) |
| 2019 | $562.20 | 39 | Celgene Corporation ($212.22) |
| 2018 | $875.99 | 42 | Novartis Pharmaceuticals Corporation ($158.23) |
| 2017 | $1,673 | 36 | Promius Pharma LLC ($512.16) |
All Payment Transactions
326 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.52 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Medline Industries LP | — | Food and Beverage | In-kind items and services | $21.40 | General |
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: Inflammation | ||||||
| 09/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Immunology | ||||||
| 09/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: Immunology | ||||||
| 08/06/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: DERMATOLOGY | ||||||
| 07/24/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Inflammation | ||||||
| 07/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: Immunology | ||||||
| 06/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Inflammation | ||||||
| 06/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: Immunology | ||||||
| 06/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Immunology | ||||||
| 06/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.49 | General |
| Category: Immunology | ||||||
| 06/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Immunology | ||||||
| 06/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: Immunology | ||||||
| 05/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: Immunology | ||||||
| 05/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Inflammation | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| AN OPEN-LABEL 24-WEEK STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF LEBRIKIZUMAB IN ADULT AND ADOLESCENT PARTICIPANTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS AND SKIN OF COLOR | Eli Lilly and Company | $2.02 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,316 | 6,871 | $1.9M | $817,859 |
| 2022 | 23 | 1,013 | 3,132 | $649,330 | $304,222 |
| 2021 | 14 | 677 | 2,129 | $275,575 | $127,563 |
| 2020 | 16 | 661 | 1,598 | $242,612 | $110,593 |
Total Patients
3,667
Total Services
13,730
Medicare Billing
$1.4M
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 61 | 1,325 | $662,500 | $331,519 | 50.0% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2023 | 66 | 1,397 | $419,100 | $233,235 | 55.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 232 | 709 | $106,400 | $50,710 | 47.7% |
| 77401 | Superficial and/or low voltage radiation treatment delivery | Office | 2023 | 62 | 1,286 | $385,800 | $49,582 | 12.9% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 60 | 201 | $54,200 | $31,188 | 57.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 52 | 151 | $45,000 | $21,788 | 48.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 89 | 169 | $33,700 | $16,344 | 48.5% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 43 | 93 | $27,800 | $10,413 | 37.5% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 52 | 127 | $38,100 | $10,030 | 26.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 72 | 88 | $17,600 | $9,350 | 53.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $14,500 | $7,193 | 49.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 62 | 142 | $14,300 | $6,722 | 47.0% |
| 77285 | Obtaining data needed to develop the optimal radiation treatment, 2 treatment areas | Office | 2023 | 14 | 16 | $9,600 | $6,580 | 68.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 76 | 76 | $15,200 | $6,348 | 41.8% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 56 | 95 | $19,000 | $5,556 | 29.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 46 | 57 | $11,400 | $4,914 | 43.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 56 | 678 | $22,374 | $4,004 | 17.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 30 | $5,400 | $2,338 | 43.3% |
| 77261 | Simple radiation therapy planning | Office | 2023 | 36 | 40 | $8,000 | $2,291 | 28.6% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 27 | 40 | $8,000 | $2,146 | 26.8% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 12 | 18 | $3,600 | $2,026 | 56.3% |
| 77332 | Design and construction of simple radiation treatment device | Office | 2023 | 41 | 57 | $11,400 | $1,929 | 16.9% |
| 77262 | Intermediate radiation therapy planning | Office | 2023 | 15 | 18 | $3,600 | $1,654 | 46.0% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2022 | 17 | 270 | $130,400 | $67,617 | 51.9% |
| G6001 | Ultrasonic guidance for placement of radiation therapy fields | Office | 2022 | 19 | 263 | $78,800 | $43,811 | 55.6% |
About Dr. Aram Kechichian, D.O
Dr. Aram Kechichian, D.O is a MOHS-Micrographic Surgery healthcare provider based in Santa Clarita, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841241486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aram Kechichian, D.O has received a total of $6,486 in payments from pharmaceutical and medical device companies, with $348.61 received in 2024. These payments were reported across 326 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,119).
As a Medicare-enrolled provider, Kechichian has provided services to 3,667 Medicare beneficiaries, totaling 13,730 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Procedural Dermatology
- Location Santa Clarita, CA
- Active Since 05/15/2006
- Last Updated 07/29/2022
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1841241486
Products in Payments
- Otezla (Drug) $989.48
- Cimzia (Drug) $928.27
- Cloderm Cream (Drug) $542.81
- COSENTYX (Biological) $483.77
- EUCRISA (Drug) $281.70
- REMICADE (Biological) $281.57
- Enbrel (Biological) $277.13
- DUPIXENT (Biological) $201.28
- TREMFYA (Drug) $170.83
- STELARA (Biological) $128.20
- TRELEGY ELLIPTA (Drug) $125.00
- Epclusa (Drug) $124.99
- ELIQUIS (Drug) $124.98
- XARELTO (Drug) $121.61
- Winlevi (Drug) $120.79
- ABSORICA (isotretinoin) (Drug) $114.44
- RYBELSUS (Drug) $105.72
- JARDIANCE (Drug) $96.43
- BOTOX COSMETIC (Biological) $94.71
- RAYOS (Drug) $80.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.